Results 41 to 50 of about 92,115 (273)

Gastric Perforation in a Patient Receiving Neoadjuvant Chemoradiotherapy

open access: yesWorld Journal of Oncology, 2015
Perioperative chemoradiotherapy is considered to be one of the standards of care for early-stage gastric cancer, especially when it involves the esophagogastric junction or greater curvature. To date, there are no reported cases of gastrointestinal perforation in the literature, including many major clinical trials of adjuvant or neoadjuvant ...
Chen, Hui   +5 more
openaire   +3 more sources

The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

open access: yesContemporary Oncology, 2017
Aim of the study : The aim was to examine the effects of neoadjuvant chemoradiotherapy on VEGF expression in patients with locally advanced rectal cancer.
David Buka   +6 more
doaj   +1 more source

Using Multi-Scale Convolutional Neural Network Based on Multi-Instance Learning to Predict the Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer

open access: yesIEEE Journal of Translational Engineering in Health and Medicine, 2022
Background: At present, radical total mesorectal excision after neoadjuvant chemoradiotherapy is crucial for locally advanced rectal cancer. Therefore, the use of histopathological images analysis technology to predict the efficacy of neoadjuvant ...
Dehai Zhang   +8 more
doaj   +1 more source

Clinicopathological characteristics of patients with esophageal cancer after neoadjuvant chemoradiotherapy.

open access: yes, 2022
Clinicopathological characteristics of patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Chung-Ping Hsu (205422)   +9 more
core   +1 more source

DataSheet_1_Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.docx

open access: yes, 2023
BackgroundThere is increasing evidence that neoadjuvant chemoradiotherapy is superior to neoadjuvant chemotherapy for patients with locally advanced gastric cancer. However, a number of studies have come to the opposite conclusion.
Yufei Lou   +15 more
core   +1 more source

Long–term survival of patients after multimodal treatment of stage IIIA(N2) non–small cell lung cancer

open access: yesУкраїнський журнал клінічної хірургії
Objective. To determine the overall and recurrence–free survival rates of patients with stage IIIA(N2) non–small cell lung cancer after various multimodal treatment regimens. Materials and methods. A comparative study of different modes of neoadjuvant
V. D. Zakharychev   +2 more
doaj   +1 more source

Characteristics of clinical trials of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy.

open access: yes, 2018
Characteristics of clinical trials of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy.
Yiming Ren (4708444)   +5 more
core   +1 more source

Impact of Radiotherapy, Chemotherapy and Surgery in Multimodal Treatment of Locally Advanced Esophageal Cancer [PDF]

open access: yes, 2011
Objectives: It was the aim of this study to assess our institutional experience with definitive chemoradiation (CRT) versus induction chemotherapy followed by CRT with or without surgery (C-CRT/S) in esophageal cancer.
Annina Lemminger   +11 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma

open access: yesDi-san junyi daxue xuebao, 2021
Objective To explore the value of neutrophil lymphocyte ratio (NLR) in predicting the efficacy of neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (ESCC). Methods Clinical data of 104 patients (92 males and 12 females) with esophageal
XIONG Kai   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy